Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of 3D Systems Corporation regarding a class action lawsuit due to alleged misleading statements and omissions made by the company during a specified class period [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from August 13, 2024, to May 12, 2025 [3]. - Allegations include that 3D Systems understated the impact of weakened customer spending and overstated its resilience in challenging industry conditions [3]. - Additionally, the updated milestone criteria in the partnership with United Therapeutics Corporation are claimed to negatively impact the company's regenerative medicine program revenue [3]. Next Steps for Shareholders - Shareholders who purchased shares during the class period are encouraged to register for the class action by August 12, 2025 [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [4]. Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors who have suffered losses due to deceit, fraud, and illegal business practices [5]. - The firm is committed to ensuring companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [5].

Core Viewpoint - Investors in 3D Systems Corporation have the opportunity to lead a securities fraud class action lawsuit due to alleged misrepresentations by the company regarding its financial health and business operations [1][2]. Summary by Relevant Sections Lawsuit Details - The lawsuit claims that from August 13, 2024, to May 12, 2025, 3D Systems failed to disclose significant information, including the understatement of weakened customer spending's impact on the business and the overstatement of the company's resilience in tough industry conditions [2]. - It is alleged that updated milestone criteria in the United Partnership would adversely affect the revenue from the Regenerative Medicine Program [2]. - The positive statements made by the defendants regarding the company's business, operations, and prospects were claimed to be materially misleading and lacked a reasonable basis during the relevant period [2]. Participation Information - Investors who suffered losses are encouraged to participate in the ongoing lawsuit before the lead plaintiff deadline of August 12, 2025 [2]. - Interested parties can contact the Law Offices of Frank R. Cruz for more information or to participate in the class action [3][4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against 3D Systems Corporation due to alleged violations of federal securities laws, encouraging affected investors to come forward before the August 12, 2025 deadline for lead plaintiff applications in a federal securities class action [3][5]. Financial Performance - 3D Systems reported Q4 2024 non-GAAP earnings-per-share of -$0.19, missing consensus estimates by $0.08, with sales revenue of $111 million, reflecting a year-over-year decline of 3.4% and missing estimates by $4.17 million [6]. - For the full year 2024, the company reported sales of $440.1 million, a decrease of 10% compared to the previous year, attributed to lower hardware systems sales due to macroeconomic factors [6]. - In Q1 2025, 3D Systems reported revenue of $94.5 million, down 8% year-over-year, and a net loss of $37 million, or $0.28 per share, more than doubling the loss from Q1 2024 [8]. Stock Price Reaction - Following the Q4 2024 results announcement, 3D Systems' stock price fell by $0.57, or 20.96%, closing at $2.15 per share [7]. - After the Q1 2025 results were released, the stock price dropped by $0.68, or 26.6%, closing at $1.87 per share [9]. Allegations and Legal Context - The complaint against 3D Systems alleges that the company and its executives made false and misleading statements regarding customer spending and the impact on the company's business, as well as the revenue from its Regenerative Medicine Program [5]. - The firm is encouraging anyone with information regarding 3D Systems' conduct to come forward, including whistleblowers and former employees [11].

Core Viewpoint - 3D Systems Corporation is facing a class action lawsuit due to significant financial losses and misleading statements made by the company regarding its business performance and outlook during the Class Period from August 13, 2024, to May 12, 2025 [1][5]. Financial Performance - On March 26, 2025, 3D Systems reported its Q4 and full-year 2024 results, missing consensus estimates for non-GAAP earnings-per-share and sales revenue, attributing the shortfall to lower hardware systems sales caused by macroeconomic factors [2]. - The company experienced a revenue reduction of $9 million in Q4 due to changes in accounting estimates related to its Regenerative Medicine program [2]. - Following this announcement, the stock price dropped by $0.57, or 21%, closing at $2.15 per share on March 27, 2025 [2]. - On May 12, 2025, 3D Systems released its Q1 2025 results, again missing estimates, primarily due to a decline in material sales linked to inventory management issues in its Healthcare Solutions segment [3]. - The company withdrew its full-year 2025 outlook, citing ongoing softness in customer capital spending and macroeconomic uncertainty [3]. - The stock price fell further by $0.68, or 26.6%, closing at $1.87 per share on May 13, 2025 [4]. Lawsuit Details - The class action lawsuit alleges that 3D Systems made materially false and misleading statements and failed to disclose adverse facts about its business and prospects during the Class Period [5]. - Specific allegations include the understatement of the impact of weakened customer spending and the overstatement of the company's resilience in challenging conditions [5]. - The lawsuit claims that the updated milestone criteria in the United Partnership negatively affected the revenue from the Regenerative Medicine Program [5].

Core Viewpoint - A class action securities lawsuit has been filed against 3D Systems Corporation, alleging securities fraud that negatively impacted investors between August 13, 2024, and May 12, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that 3D Systems Corporation understated the impact of weakened customer spending on its business while overstating its resilience in challenging industry conditions [2]. - It is alleged that updated milestone criteria in the partnership with United Therapeutics Corporation would adversely affect the revenue from the Company's regenerative medicine program [2]. - As a result, the Company's public statements were deemed materially false and misleading throughout the relevant period [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until August 12, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In 3D Systems To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in 3D System between August 13, 2024 and May 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, June 28, 2025 (GLOBE ...

NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- , June 27, 2025 – Levi & Korsinsky, LLP notifies investors in 3D Systems Corporation ("3D Systems Corporation" or the "Company") (NYSE: DDD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of 3D Systems Corporation investors who were adversely affected by alleged securities fraud between August 13, 2024 and May 12, 2025. Follow the link below to get more information and be contacted by a member of our team: htt ...

Group 1 - The article initiates coverage on 3D Systems Corporation (NYSE: DDD) with a Strong Buy rating and a price target of $4, highlighting its end-to-end additive manufacturing and digital manufacturing capabilities across various sectors including healthcare, dental, aerospace, and biotech [1] - Moretus Research focuses on identifying companies with durable business models, mispriced cash flow potential, and intelligent capital allocation, applying a structured framework to deliver high-quality equity research [1] - The valuation approach used by Moretus Research emphasizes pragmatic, sector-relevant multiples tailored to each company's business model and capital structure, aiming for comparability, simplicity, and relevance [1] Group 2 - Research coverage by Moretus tends to favor underappreciated companies undergoing structural change or temporary dislocation, where disciplined analysis can lead to asymmetric returns [1] - Moretus Research aims to raise the standard for independent investment research by providing professional-grade insights, actionable valuation, and a strong filter for what truly matters in modern equity analysis [1]

Core Viewpoint - A class action lawsuit has been filed against 3D Systems Corporation, alleging that the company made misleading statements regarding its financial health and the impact of customer spending on its business [3][4]. Group 1: Class Action Details - The class action represents investors who purchased securities between August 13, 2024, and May 12, 2025, with a deadline of August 12, 2025, to file a lead plaintiff motion [1]. - The Portnoy Law Firm is offering complimentary case evaluations to investors seeking to recover losses [2]. Group 2: Allegations Against 3D Systems - The lawsuit claims that 3D Systems understated the impact of weakened customer spending and overstated its resilience to market challenges [3]. - It is alleged that changes in the partnership with United Therapeutics Corporation would negatively affect revenue from the Regenerative Medicine Program [3]. Group 3: Financial Performance - On March 26, 2025, 3D Systems reported a Q4 non-GAAP loss of $0.19 per share, missing consensus estimates by $0.08, with Q4 revenue of $111 million, down 3.4% year-over-year [6]. - The full-year revenue for 2024 was reported at $440.1 million, reflecting a 10% decline year-over-year due to lower hardware sales and macroeconomic challenges [6]. - Following the Q1 2025 results announcement on May 12, 2025, the stock fell more than 26%, with a reported net loss of $37 million, more than double the loss from Q1 2024 [4][6].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of 3D Systems Corporation regarding a class action lawsuit due to alleged misleading statements and omissions made by the company during a specified class period [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from August 13, 2024, to May 12, 2025 [3]. - Allegations include that 3D Systems understated the impact of weakened customer spending and overstated its resilience in challenging industry conditions [3]. - Additionally, the updated milestone criteria in the partnership with United Therapeutics Corporation are claimed to negatively impact the company's regenerative medicine program revenue [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by the deadline of August 12, 2025, to potentially become lead plaintiffs [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case [4]. Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights and seeks recovery for those who suffered losses due to deceitful practices by companies [5]. - The firm emphasizes the importance of responsible business practices and good corporate citizenship [5].